Nippon Shinyaku Launches Regtect Tablets For Alcoholism In Japan
This article was originally published in PharmAsia News
Executive Summary
Nippon Shinyaku launched its abstinence adjuvant Regtect (acamprosate) for alcohol-dependent patients May 27.